New patent expiration for Mainpointe drug TUXARIN ER

Annual Drug Patent Expirations for TUXARIN+ER Tuxarin Er is a drug marketed by Mainpointe and is included in one NDA. It is available from two suppliers. There are four patents… The post New patent expiration for Mainpointe drug TUXARIN ER appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!